Please assess the completion status of the following clinical trial:

Trial Title: CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Signed Informed Consent Form and HIPAA (Health Insurance Portability and Accountability Act ) document~* Patient-reported history of dry eye in both eyes~* Current use of over-the-counter and/or prescription eye drops for dry eye symptoms~* Ability and willingness to follow instructions, including participation in all study assessments and visits~Exclusion Criteria:~* Women who are pregnant, nursing or planning a pregnancy~* Unwillingness to submit a blood pregnancy test at screening and at the last visit (or early termination visit) if of childbearing potential, or unwillingness to use acceptable means of birth control~* Clinically significant slit-lamp findings or abnormal lid anatomy at screening~* DED secondary to scarring or ocular or periocular malignancy~* History of herpetic keratitis~* Active ocular allergies or ocular allergies that are expected to be active during the study period~* Ongoing ocular or systemic infection at screening or baseline~* Wear of contact lenses within 3 months prior to screening or anticipated use of contact lenses during the study~* History of no response to previous topical Cyclosporine A and/or use of topical Cyclosporine A within 6 months prior to screening~* Intra-ocular surgery or ocular laser surgery within the previous 6 months, or have any planned ocular and/or lid surgeries over the study period~* Presence of an uncontrolled systemic disease~* Presence of a known allergy and/or sensitivity to the study drug or its components

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- CyclASol Ophthalmic Solution 1 (Type: EXPERIMENTAL): Cyclosporine A solution (dose-level 1) in vehicle
- CyclASol Ophthalmic Solution 2 (Type: EXPERIMENTAL): Cyclosporine A solution (dose-level 2) in vehicle
- Placebo Ophthalmic Solution (Type: PLACEBO_COMPARATOR): Vehicle only
- Restasis (Type: ACTIVE_COMPARATOR): Cyclosporine A 0.05% ophthalmic emulsion

Based on this trial design, predict the completion outcome and termination type (if applicable).